View in EDS HTML Full Text PDF Full Text

Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study.

Saved in:
Bibliographic Details
Title: Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors—retrospective study.
Authors: Higaki, Hajime1 (AUTHOR), Nishioka, Kentaro2 (AUTHOR), Otsuka, Manami1,3 (AUTHOR), Nishikawa, Noboru4 (AUTHOR), Shido, Motoyasu1 (AUTHOR), Minatogawa, Hideki3 (AUTHOR), Nishikawa, Yukiko3 (AUTHOR), Takashina, Rikiya3 (AUTHOR), Hashimoto, Takayuki2 (AUTHOR), Katoh, Norio1 (AUTHOR), Taguchi, Hiroshi4 (AUTHOR), Kinoshita, Rumiko4 (AUTHOR), Yasuda, Koichi4 (AUTHOR), Mori, Takashi4 (AUTHOR), Uchinami, Yusuke1 (AUTHOR), Koizumi, Fuki1 (AUTHOR), Fujita, Yoshihiro1 (AUTHOR), Takahashi, Shuhei1 (AUTHOR), Hattori, Takahiro1 (AUTHOR), Nishiyama, Noriaki3 (AUTHOR)
Source: Radiation Oncology. 2/7/2023, Vol. 18 Issue 1, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1748717X
DOI:10.1186/s13014-023-02218-3